Solid Biosciences Inc. — Director's Dealing 2018

Jan 26, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Solid Biosciences, LLC (SLDB)
CIK: 0001707502
Period of Report: 2018-01-25

Reporting Person: Koppel Adam (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1689444	Indirect

Footnotes

F1: Represents shares held directly by BCLS SB Investco, LP ("BCLS").

F2: The governance, investment strategy and decision-making process with respect to investments held by BCLS is directed by Bain Capital Life Sciences Investors, LLC, whose managers are Jeffrey Schwartz and Adam Koppel. By virtue of the relationships described in these footnotes, Dr. Koppel may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by BCLS. Dr. Koppel disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.